Keros Therapeutics shares owned by Woodline Partners
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Woodline Partners
from 13F filings
Historical chart of Woodline Partners investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Woodline Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $23M | 718k | 31.88 |
| 2023-06-30 | $11M | 280k | 40.18 |
| 2023-03-31 | $8.5M | 198k | 42.70 |
| 2022-12-31 | $9.4M | 197k | 48.02 |
| 2022-09-30 | $13M | 343k | 37.62 |
| 2022-03-31 | $14M | 257k | 54.38 |
| 2021-12-31 | $4.5M | 76k | 58.51 |
| 2021-09-30 | $7.4M | 188k | 39.56 |